Search
Remarks by Acting Commissioner Ned Sharpless at the FDA Public Hearing on The Future of Biosimilar Insulin - 05/13/2019
… icials/remarks-acting-commissioner-ned-sharpless-fda-public-hearing-future-biosimilar-insulin-05132019 … White Oak, MD … thank you for joining us for today’s very important Public Hearing. The world of public health has never been as … treatments and devices. The subject of today’s public hearing -- facilitating the efficient development of …
Cellular, Tissue and Gene Therapies Advisory Committee May 8, 2020 Meeting Announcement - 05/08/2020
… open sessions of the meeting including the Open Public Hearing (OPH) of the meeting can be accessed through the … reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Allergenic Products Advisory Committee October 28, 2021 Meeting Announcement - 10/28/2021
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Cancelled- Allergenic Products Advisory Committee May 15, 2020 Meeting Announcement - 05/15/2020
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee October 2, 2020 Meeting Announcement - 10/02/2020
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee March 4, 2020 Meeting Announcement - 03/04/2020
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Cellular, Tissue, and Gene Therapies Advisory Committee March 10, 2022 Meeting Announcement - 03/10/2022
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Blood Products Advisory Committee December 8, 2022 Meeting Announcement - 12/08/2022
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Blood Products Advisory Committee November 4, 2021 Meeting Announcement - 11/04/2021
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
POSTPONED- Blood Products Advisory Committee April 2-3, 2020 Meeting Announcement - 04/02/2020
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee October 6, 2022 Meeting Announcement - 10/06/2022
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Cellular, Tissue, and Gene Therapies Advisory Committee October 31, 2023 Meeting Announcement - 10/31/2023
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee October 5, 2023 Meeting Announcement - 10/05/2023
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee June 15, 2023 Meeting Announcement - 06/15/2023
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee May 16, 2024 Meeting Announcement - 05/16/2024
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Blood Products Advisory Committee May 9, 2024 Meeting Announcement - 05/09/2024
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Announcement - 10/22/2020
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee October 14-15, 2021 Meeting Announcement - 10/14/2021
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee October 26, 2021 Meeting Announcement - 10/26/2021
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee September 17, 2021 Meeting Announcement - 09/17/2021
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee February 26, 2021 Meeting Announcement - 02/26/2021
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee March 5, 2021 Meeting Announcement - 03/05/2021
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Cellular, Tissue, and Gene Therapies Advisory Committee April 15, 2021 Meeting Announcement - 04/15/2021
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Announcement - 12/10/2020
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …
Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Announcement - 12/17/2020
… reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested …